Neogen Corp. (NEOG)
11.98
-1.04
(-7.96%)
USD |
NASDAQ |
Oct 06, 16:00
13.27
+1.30
(+10.81%)
After-Hours: 19:26
Neogen Enterprise Value : 3.459B for Oct. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 3.459B |
| October 02, 2026 | 3.272B |
| October 01, 2026 | 3.291B |
| September 30, 2026 | 3.413B |
| September 29, 2026 | 3.398B |
| September 28, 2026 | 3.613B |
| September 25, 2026 | 3.622B |
| September 24, 2026 | 3.600B |
| September 23, 2026 | 3.581B |
| September 22, 2026 | 3.670B |
| September 21, 2026 | 3.589B |
| September 18, 2026 | 3.457B |
| September 17, 2026 | 3.420B |
| September 16, 2026 | 3.359B |
| September 15, 2026 | 3.293B |
| September 14, 2026 | 3.228B |
| September 11, 2026 | 3.191B |
| September 10, 2026 | 3.189B |
| September 09, 2026 | 3.221B |
| September 08, 2026 | 3.214B |
| September 04, 2026 | 3.202B |
| September 03, 2026 | 3.161B |
| September 02, 2026 | 3.198B |
| September 01, 2026 | 3.161B |
| August 31, 2026 | 3.143B |
| Date | Value |
|---|---|
| August 28, 2026 | 3.165B |
| August 27, 2026 | 3.182B |
| August 26, 2026 | 3.174B |
| August 25, 2026 | 3.161B |
| August 24, 2026 | 3.152B |
| August 21, 2026 | 3.228B |
| August 20, 2026 | 3.202B |
| August 19, 2026 | 3.272B |
| August 18, 2026 | 3.145B |
| August 17, 2026 | 3.211B |
| August 14, 2026 | 3.163B |
| August 13, 2026 | 3.215B |
| August 12, 2026 | 3.121B |
| August 11, 2026 | 3.128B |
| August 10, 2026 | 3.108B |
| August 07, 2026 | 3.124B |
| August 06, 2026 | 3.087B |
| August 05, 2026 | 3.108B |
| August 04, 2026 | 3.198B |
| August 03, 2026 | 3.217B |
| July 31, 2026 | 3.248B |
| July 30, 2026 | 3.137B |
| July 29, 2026 | 2.673B |
| July 28, 2026 | 2.627B |
| July 27, 2026 | 2.660B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 42.47B |
| QuidelOrtho Corp. | 3.781B |
| Aspira Women's Health, Inc. | 13.99M |
| VolitionRX Ltd. | 10.04M |
| Lucid Diagnostics, Inc. | 104.68M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -11.30M |
| Revenue (Quarterly) | 225.30M |
| Total Expenses (Quarterly) | 236.60M |
| EPS Diluted (Quarterly) | -0.0519 |
| Gross Profit Margin (Quarterly) | 37.59% |
| Profit Margin (Quarterly) | -5.02% |
| Earnings Yield | -0.30% |
| Normalized Earnings Yield | -0.1194 |